Russin
Alicia Michelle Powers Russin, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20150138631 | Systems and Methods to More Accurately Estimate a Fluorine Concentration in a Source Laser - In master oscillator-power amplifier (MOPA) systems for generating laser light, a fluorine concentration in each of the master oscillator and power amplifier chambers is maintained. While sensors at the chambers can measure certain values of some variables, the sensors do not directly measure fluorine concentration. As a further complication, the values received from the sensors are known to be affected by various specified variables. To estimate the effect on the received values, an RLS algorithm and covariance matrix are used. To ensure that the RLS algorithm is responsive to recent changes in a specified variable, portions of the covariance matrix are reset to more quickly and more heavily weight the more recent values. | 05-21-2015 |
Michael Russin, East Rockaway, NY US
Patent application number | Description | Published |
---|---|---|
20120096082 | DYNAMIC DISPLAY USING PUSHED-STREAMED DATA - A system and method for dynamic updating of display windows using a pushed stream of data. | 04-19-2012 |
20140351325 | DYNAMIC DISPLAY USING PUSHED STREAMED DATA - A system and method for dynamic updating of display windows using a pushed stream of data. | 11-27-2014 |
Michael Russin, Orono, MN US
Patent application number | Description | Published |
---|---|---|
20150173674 | DETECTING AND COMMUNICATING HEALTH CONDITIONS - This disclosure provides devices, systems, and methods for detecting physiological parameters, and for communicating information related to the detected physiological parameters to the user, the user's caregiver, and medical personnel. For example, some systems described herein can be configured to detect a user's hypoglycemic event, and to thereafter alert the user, caregivers, and medical personnel to the occurrence of the hypoglycemic event. | 06-25-2015 |
Ted Anthony Russin, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090136644 | Multi-Layer Self-Separating Gel - A multi-layer self-separating gel is described. A food composition comprising a first layer and a second layer comprises water, low acyl gellan gum, and an emulsifier. The composition can further comprise a third layer. A process of preparing a multi-layered food composition can comprise the steps of dry blending the low acyl gellan gum and the emulsifier to form a dry blend; adding the dry blend to water to form a mixture; agitating the mixture; heating the mixture to a temperature above about 54° C.; subjecting the mixture to high shear mixing at a temperature above about 54° C.; cooling the mixture to about 54° C. while continuing to mix said mixture; and ceasing the mixing of the mixture. Lack of protein in the gel minimizes its allergenicity; the gel is vegetarian; and the gel's physical properties allow for the potential of creating a shelf stable product. | 05-28-2009 |
Timothy J. Russin, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20100247436 | In vivo photodynamic therapy of cancer via a near infrared agent encapsulated in calcium phosphate nanoparticles - Nano-encapsulated photosensitizers and their use in the treatment of tumors and/or imaging is described. Preferably, the photosensitizers are encapsulated in a calcium phosphate nanoparticle (CPNP). Encapsulating the PS in a CPNP increases the half-life of the PS, increases absorption of the PS into the target cell tissue, increases the photostability of the PS, increases the photoefficiency of the PS, increases in vivo retention of the PS, or combinations thereof, ultimately making it a highly efficacious agent for use in photodynamic therapy, imaging target tissues, vessels, or tumors, and/or detecting or locating tumors. | 09-30-2010 |
20140154325 | IN VIVO PHOTODYNAMIC THERAPY OF CANCER VIA A NEAR INFRARED AGENT ENCAPSULATED IN CALCIUM PHOSPHATE NANOPARTICLES - Nano-encapsulated photosensitizers and their use in the treatment of tumors and/or imaging is described. Preferably, the photosensitizers are encapsulated in a calcium phosphate nanoparticle (CPNP). Encapsulating the PS in a CPNP increases the half-life of the PS, increases absorption of the PS into the target cell tissue, increases the photostability of the PS, increases the photoefficiency of the PS, increases in vivo retention of the PS, or combinations thereof, ultimately making it a highly efficacious agent for use in photodynamic therapy, imaging target tissues, vessels, or tumors, and/or detecting or locating tumors. | 06-05-2014 |